Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

16.32
Delayed Data
As of Feb 24
 -0.51 / -3.03%
Today’s Change
12.25
Today|||52-Week Range
27.02
-9.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues134.2M390.4M342.7M455.9M
 
 
 
 
 
Cost of Goods Sold5.5M13.3M65.5M87.4M
 
 
 
 
 
Depreciation And Amortization6.2M12.0M85.7M--
 
 
 
 
 
Operating ExpensesGross Income122.6M365.1M191.5M368.5M
 
 
 
 
 
General Expenses113.1M127.8M208.3M237.1M
 
 
 
 
 
Other Operating Expenses0.000.000.00106.8M
 
 
Research And Development8.1M7.1M17.5M32.6M
 
 
 
 
 
Total Operating Expenses124.8M153.1M359.5M431.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income9.4M237.2M-16.8M24.5M
 
 
 
 
 
Extraordinary Credit500.0K--34.0M--
 
 
 
Extraordinary Charge-100.0K-2.8M-69.9M-5.8M
 
 
 
 
 
Interest Expense On Debt5.4M21.5M71.1M83.7M
 
 
 
 
 
Other Expenses0.000.000.00485.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income4.6M213.1M-123.2M-64.5M
 
 
 
 
 
Income Taxes-38.7M-81.3M-47.5M-24.2M
 
 
 
 
 
Net Income43.3M131.8M-75.7M-88.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS56.7M58.3M60.1M61.3M
 
 
 
 
 
Shares To Calculate EPS Diluted57.5M66.3M60.1M61.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.75$2.05-$1.26-$1.45
 
 
 
 
 
EPS Diluted$0.75$2.05-$1.26-$1.45